Download:
pdf |
pdfDocument Metadata:CDC-2017-0011-0002
Document Details
Docket ID:
CDC-2017-0011
Docket Title:
A Novel Framework for Structuring Industry-Tuned
Public-Private Partnerships and Economic Incentives for U.S.
Health Emergency Preparedness and Response 0920-17NW
Document File:
Docket Phase:
Notice
Phase Sequence:
1
Original Document ID:
CDC-2017-0011-DRAFT-0002
Current Document ID:
CDC-2017-0011-0002
Title:
: Kermit Kubitz Comment from (name)
Number of Attachments:
0
Document Type:
PUBLIC SUBMISSIONS
Document Subtype:
Comment on Document ID:
CDC-2017-0011-0001
Comment on Document Title: A Novel Framework for Structuring Industry-Tuned
Public-Private Partnerships and Economic Incentives for U.S.
Health Emergency Preparedness and Response 0920-17NW 2017-08540
Status:
Posted
Received Date:
06/26/2017
Date Posted:
06/28/2017
Posting Restriction:
No restrictions
Submission Type:
Web
Number of Submissions:
1
Document Optional Details
Status Set Date:
06/28/2017
Current Assignee:
NA
Status Set By:
Burroughs-Stokes, Kennya LaTrice (CDC)
Comment Start Date:
04/27/2017
Comment Due Date:
06/26/2017
Tracking Number:
1k1-8x6r-v9o7
Page Count:
1
Total Page Count
Including Attachments:
1
Submitter Info
Comment:
The notion of public private partnerships may be useful, but
the CDC interviews should ensure that not just industry
leaders but small innovative companies are included. Dealing
with "Big Pharma" alone may not lead to the best results as
small companies like Biocryst or Radius or other BSAV
developers may have good ideas.
First Name:
Kermit
Last Name:
Kubitz
ZIP/Postal Code:
94127
Email Address:
Mesondk@yahoo.com
Organization Name:
Cover Page:
Document Optional Details
Submitter Info
Comment:
The notion of public private partnerships may be useful, but
the CDC interviews should ensure that not just industry
leaders but small innovative companies are included. Dealing
with "Big Pharma" alone may not lead to the best results as
small companies like Biocryst or Radius or other BSAV
developers may have good ideas.
First Name:
Kermit
Last Name:
Kubitz
ZIP/Postal Code:
94127
Email Address:
Mesondk@yahoo.com
Organization Name:
Cover Page:
Document Optional Details
Submitter Info
Comment:
The notion of public private partnerships may be useful, but
the CDC interviews should ensure that not just industry
leaders but small innovative companies are included. Dealing
with "Big Pharma" alone may not lead to the best results as
small companies like Biocryst or Radius or other BSAV
developers may have good ideas.
First Name:
Kermit
Last Name:
Kubitz
ZIP/Postal Code:
94127
Email Address:
Mesondk@yahoo.com
Organization Name:
Cover Page:
| File Type | application/pdf |
| File Modified | 0000-00-00 |
| File Created | 0000-00-00 |